120 related articles for article (PubMed ID: 11596572)
1. High-dose cyclophosphamide to treat severe aplastic anemia.
Ann Intern Med; 2001 Oct; 135(7):S-1. PubMed ID: 11596572
[No Abstract] [Full Text] [Related]
2. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
Brodsky RA; Sensenbrenner LL; Smith BD; Dorr D; Seaman PJ; Lee SM; Karp JE; Brodsky I; Jones RJ
Ann Intern Med; 2001 Oct; 135(7):477-83. PubMed ID: 11578150
[TBL] [Abstract][Full Text] [Related]
3. [The use of cyclophosphane in the immunodepressive therapy of severe aplastic anemia].
Fedorovskaia NA; Istomina LA; Kopaneva TG; Iugov IuI; Timkina EN; Minakov VN; Kudriavtseva AV
Ter Arkh; 1997; 69(4):61-4. PubMed ID: 9213965
[TBL] [Abstract][Full Text] [Related]
4. High-dose cyclophosphamide as salvage therapy for severe aplastic anemia.
Brodsky RA; Chen AR; Brodsky I; Jones RJ
Exp Hematol; 2004 May; 32(5):435-40. PubMed ID: 15145211
[TBL] [Abstract][Full Text] [Related]
5. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
Tisdale JF; Dunn DE; Geller N; Plante M; Nunez O; Dunbar CE; Barrett AJ; Walsh TJ; Rosenfeld SJ; Young NS
Lancet; 2000 Nov; 356(9241):1554-9. PubMed ID: 11075769
[TBL] [Abstract][Full Text] [Related]
6. High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
DeZern AE; Petri M; Drachman DB; Kerr D; Hammond ER; Kowalski J; Tsai HL; Loeb DM; Anhalt G; Wigley F; Jones RJ; Brodsky RA
Medicine (Baltimore); 2011 Mar; 90(2):89-98. PubMed ID: 21358440
[TBL] [Abstract][Full Text] [Related]
7. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
Jaime-Pérez JC; González-Llano O; Gómez-Almaguer D
Am J Hematol; 2001 Jan; 66(1):71. PubMed ID: 11426504
[No Abstract] [Full Text] [Related]
8. Rapid and complete reconstitution of autologous haemopoiesis after cord blood infusion in treatment-naive patients with severe aplastic anemia receiving high-dose cyclophosphamide/ATG therapy.
Li Y; Sheng Z; Niu S; Ge L; Ren C; Zou Y
Eur J Haematol; 2013 Jan; 90(1):45-50. PubMed ID: 23106334
[TBL] [Abstract][Full Text] [Related]
9. High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children.
Audino AN; Blatt J; Carcamo B; Castaneda V; Dinndorf P; Wang WC; Whitlock JA; Hord JD
Pediatr Blood Cancer; 2010 Feb; 54(2):269-72. PubMed ID: 19827142
[TBL] [Abstract][Full Text] [Related]
10. High-dose cyclophosphamide in aplastic anaemia.
Brodsky RA; Jones RJ
Lancet; 2001 Apr; 357(9262):1128-9. PubMed ID: 11303606
[No Abstract] [Full Text] [Related]
11. High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia.
Zhang F; Zhang L; Jing L; Zhou K; Wang H; Peng G; Li Y; Li Y; Li J; Ye L; Shi L; Fan H; Zhao X; Chu Y; Hao Y; Wang J
Exp Hematol; 2013 Apr; 41(4):328-34. PubMed ID: 23313080
[TBL] [Abstract][Full Text] [Related]
12. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for cure after immunosuppressive therapy of aplastic anemia.
Viollier R; Tichelli A
Acta Haematol; 2000; 103(1):55-62. PubMed ID: 10705160
[TBL] [Abstract][Full Text] [Related]
14. High-dose cyclophosphamide for aplastic anemia and autoimmunity.
Brodsky RA
Curr Opin Oncol; 2002 Mar; 14(2):143-6. PubMed ID: 11880702
[TBL] [Abstract][Full Text] [Related]
15. High-dose cyclophosphamide for treatment of aplastic anemia.
Young NS; Tisdale JF
Ann Intern Med; 2002 Sep; 137(6):549-50; author reply 549-50. PubMed ID: 12230370
[No Abstract] [Full Text] [Related]
16. High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.
Gamper CJ; Takemoto CM; Chen AR; Symons HJ; Loeb DM; Casella JF; Dezern AE; King KE; McGonigle AM; Jones RJ; Brodsky RA
J Pediatr Hematol Oncol; 2016 Nov; 38(8):627-635. PubMed ID: 27467367
[TBL] [Abstract][Full Text] [Related]
17. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
Brodsky RA; Petri M; Smith BD; Seifter EJ; Spivak JL; Styler M; Dang CV; Brodsky I; Jones RJ
Ann Intern Med; 1998 Dec; 129(12):1031-5. PubMed ID: 9867758
[TBL] [Abstract][Full Text] [Related]
18. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
Savage WJ; DeRusso PA; Resar LM; Chen AR; Higman MA; Loeb DM; Jones RJ; Brodsky RA
Pediatr Blood Cancer; 2007 Dec; 49(7):947-51. PubMed ID: 17252566
[TBL] [Abstract][Full Text] [Related]
20. Frontline therapy of severe aplastic anaemia with fludarabine, cyclophosphamide and ciclosporin.
Liu Q; Zhao X; Xu N; Huang P; Li S; Zhang F; Wang J
Br J Haematol; 2015 Nov; 171(3):427-30. PubMed ID: 25824311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
